EN DE
Watch AVRUPAKENT GMYO for free: we tell you when fair value or trend changes.
Data-driven stock valuation

AVRUPAKENT GMYO (AVPGY) fair value: what the stock is really worth

As of Oct 28, 2026: fair value (intrinsic value) of AVRUPAKENT GMYO stock TRY 118, price TRY 47.64, upside +148.4%, quality 56 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Real Estate TR

AG AVRUPAKENT GMYO logo Thin data Oct 27, 2026

AVRUPAKENT GMYO

AVPGY · IS
Undervalued, but sidewaysFair value well above the price and solid quality, but no uptrend.Plus: Even on cautious assumptions the value is 54% above the price (73.54 TRY).

The stock costs 60% less than our calculation considers fair.

Fair value 118.35 TRY · Strongly undervalued (60%)
Solidly profitable · 15.8% net margin (TTM)
Low debt
Generates free cash flow
Ranks above peers (10/14)
Quality 56/100
Mixed Growth (revenue YoY −29.9 %/yr in TRY)
Moderate moat 56/100 · thin data
Thin data
⚠ Small free float

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

63.83 TRY 30.73 TRY Fair Value 118.35 TRY Dec 2023 Oct 2026

White line = price, green steps = our fair value per fiscal year. As of Oct 27, 2026.

How to read this chart

34‑month range 30.73 TRY – 63.83 TRY · fair‑value band 73.54 TRY – 191.17 TRY · the 47.64 TRY price screens below the 118.35 TRY fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Oct 27, 2026.

Follow AVRUPAKENT GMYO in your weekly email

Every Wednesday you see whether AVRUPAKENT GMYO is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Avrupakent Gayrimenkul Yatirim Ortakligi Anonim Sirketi engages in the real estate development, leasing, and business administration activities in Turkey. It operates residential, shopping malls, and other real estate properties. The company was founded in 1977 and is based in Istanbul, Turkey.

Stock analysis

AVRUPAKENT GMYO (AVPGY) currently trades at 47.64 TRY, while our model-based Fair Value estimate is 118.35 TRY, implying the stock looks roughly 59.7% undervalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of 152.91 TRY per share, and 16 of the 16 models we run sit above the 47.64 TRY price.

Bear case: the Dividend Discount group reads lowest at 51.49 TRY, and 0 of the 16 models stay below the price. Data coverage for this calculation is low.

Scenario range: 73.54 TRY (bear) to 191.17 TRY (bull), the price of 47.64 TRY sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 56/100 (solid quality), in the Real Estate sector.

Mixed Growth: Spin-off in 2024: revenue and profit before it include the divested business. Growth is measured afresh from 2024.

AVRUPAKENT GMYO reported revenue of 6.8B TRY in FY2026 versus 171M TRY in FY2022, a compound +151.6%/yr. Reported net income was 1.6B TRY in FY2026, compounding +14.2%/yr from FY2022. FY2022 was a trough year, so the rate overstates the trend.

Key figures

Market cap 19.1B TRY (≈ $382M) Small · P/E ratio 10.2 · P/S ratio 2.40 · EPS (TTM) 4.68 TRY · Dividend yield 11.3% · Net margin 23.5% · Return on equity 2.5% · Return on assets (EBIT) 7.7%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 56 out of 100 (low confidence).

What moves the price

The share trades about 25% below its 52-week high and 10% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Real Estate peers we cover trades at −49% fair-value upside, at 148%, AVPGY screens cheaper than that median.

Fair Value models

Bear 73.54 TRY Fair Value 118.35 TRY Bull 191.17 TRY
Price 47.64 TRY · Upside +148.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 4 months old). Earnings retained since then (1.55 TRY per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 112.99 TRY 152.23 TRY 264.98 TRY 76
Growth DCF 106.08 TRY 161.00 TRY 246.99 TRY 75
Residual Income 65.21 TRY 62.93 TRY 62.60 TRY 74
All 16 models by family
DCF Models
FCF DCF 112.99 TRY 152.23 TRY 264.98 TRY 76
5Y Revenue Exit 83.24 TRY 129.17 TRY 224.19 TRY 68
5Y EBITDA Exit 95.02 TRY 152.91 TRY 265.86 TRY 70
10Y Revenue Exit 92.86 TRY 168.19 TRY 207.20 TRY 65
10Y EBITDA Exit 101.40 TRY 188.26 TRY 329.79 TRY 63
Dividend Discount
Gordon GGM 33.45 TRY 52.72 TRY 65.51 TRY 67
DDM Multi-Stage 33.45 TRY 51.49 TRY 56.98 TRY 65
Multiples
P/S Multiple 51.29 TRY 68.38 TRY 85.48 TRY 58
P/B Multiple 150.84 TRY 201.12 TRY 251.40 TRY 55
EV/EBIT 106.78 TRY 142.37 TRY 177.97 TRY 66
EV/EBITDA 82.69 TRY 110.25 TRY 137.82 TRY 67
EV/Revenue 58.88 TRY 84.12 TRY 109.37 TRY 53
Asset-Based
NCAV (Graham) 50.28 TRY 67.37 TRY 100.56 TRY 54
Growth DCF
Growth DCF 106.08 TRY 161.00 TRY 246.99 TRY 75
Rev-Margin DCF 89.61 TRY 142.63 TRY 252.84 TRY 68
Economic Profit
Residual Income 65.21 TRY 62.93 TRY 62.60 TRY 74

Open the full fair value analysis →

Quality Score breakdown

Overall quality 56/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 33
How much profit the company makes from its sales and capital
Quality Growth 5
Are margins and returns getting better?
Cashflow 100
Do the profits arrive as real cash?
Financial strength 76
Debt, balance sheet and risk of trouble
Investment 33
Does it invest with discipline instead of growing at any price?
Low Volatility 82
How calm the share price moves, does not count
Momentum 30
Price trend of the last 3 to 12 months, does not count
Near the 52-week high 21
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 55/100
Spin-off in 2024: revenue and profit before it include the divested business. Growth is measured afresh from 2024.
What shareholders gained per year (last 5 years), in TRY ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TRY: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+36.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+25.1%
Dividend (yield on the price)11.3%
Profit margin 2021 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.9% → 82%

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−11.8%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Turkey: IMF forecast 19.3% a year to 2030, 28.5% from 2016 to 2025) that is about −26.1% a year for the price.

Watch AVPGY, get fair value alerts →

Compare AVRUPAKENT GMYO with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Real Estate - Diversified · 129 stocks

Beats the industry median on 9/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 56 · Above median
Fair Value upside +148.4% · Top 25%
Profitability
Return on equity (12 months) 2.5% · Below median
Return on assets 3.2% · Above median
Net margin (12 months) 15.8% · Above median
Operating margin (12 months) 36.1% · Above median
Growth and dividend
Revenue growth (quarter YoY) −26.6% · Bottom 25%
Dividend yield (12 months) 11.3% · Top 25%

Valuation Multiplesvs Real Estate - Diversified median · lower = cheaper

P/E (12 months) 10.2× · Cheaper than median
P/B 0.47× · Cheaper than median
P/S (12 months) 2.95× · Pricier than median
Price / free cash flow 4.4× · Cheapest 25%
EV/EBITDA 22.8× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 37
FUTURE (revenue growth)0 · sector 7
PAST (return on equity)10 · sector 18
HEALTH (low debt)100 · sector 75
DIVIDEND (yield)100 · sector 63

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Real Estate - Diversified stocks, each showing price versus our Fair Value estimate.

Explore undervalued stocks

More undervalued Real Estate stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "AVRUPAKENT GMYO Fair Value". https://www.fairvalue-calculator.com/stock/AVPGY

Frequently asked questions

Is AVRUPAKENT GMYO (AVPGY) overvalued or undervalued?
As of Oct 27, 2026, our model estimates a fair value of 118.35 TRY versus a price of 47.64 TRY, about +148% upside (undervalued).
What is the fair value of AVPGY?
Our model-based fair value for AVRUPAKENT GMYO is 118.35 TRY (as of Oct 27, 2026), built from audited fundamentals. The current price: 47.64 TRY.
What is the quality score of AVPGY?
AVRUPAKENT GMYO has a Quality Score of 56/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for AVRUPAKENT GMYO (AVPGY)?
Our model-based price target is the fair value of 118.35 TRY (as of Oct 27, 2026) from 16 valuation models. Cautious scenario 73.54 TRY, optimistic scenario 191.17 TRY. It is a calculation from audited fundamentals, not an analyst target.
What is the AVRUPAKENT GMYO stock forecast for 2026?
Our models put fair value at 118.35 TRY, about +148% upside versus a price of 47.64 TRY (undervalued). Cautious scenario 73.54 TRY, optimistic scenario 191.17 TRY. The calculation is refreshed regularly with new filings.
What is the revenue of AVRUPAKENT GMYO (AVPGY)?
AVRUPAKENT GMYO reported trailing-twelve-month revenue of about 6.5B TRY (latest available figure, as of Oct 27, 2026).
Does AVRUPAKENT GMYO pay a dividend?
AVRUPAKENT GMYO currently shows a dividend yield of 11.31% relative to its recent price (as of Oct 27, 2026).
What growth is priced into AVRUPAKENT GMYO (AVPGY)?
For today's price to be fair in a discounted-cash-flow model, AVRUPAKENT GMYO would have to grow free cash flow by -11.8 % per year for five years (discount rate 14.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +47.1 % per year. As of Oct 27, 2026.
What discount rate (WACC) does the fair value of AVPGY use?
Our models discount AVRUPAKENT GMYO at 14.2 %: a base by market capitalisation (small), damped by beta 0.45, country premium for Turkey. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For AVRUPAKENT GMYO that is -11.8 % per year a year over ten years, using the same discount rate (14.2 %) and the same formula as our fair value.
How much growth has AVRUPAKENT GMYO (AVPGY) delivered so far?
Over the past 5 years revenue at AVRUPAKENT GMYO grew +47.1 % a year. The price currently implies -11.8 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of AVRUPAKENT GMYO (AVPGY) growing?
The median revenue growth in the sector is +2.4 % a year. That is the yardstick for the growth priced into AVRUPAKENT GMYO (-11.8 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of AVRUPAKENT GMYO (AVPGY)?
The free-cash-flow yield on the price is 22.55 %: that much free cash flow AVRUPAKENT GMYO produces per unit of market value. When it exceeds the discount rate of our models (14.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of AVRUPAKENT GMYO (AVPGY)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For AVRUPAKENT GMYO it is 118.35 TRY per share (as of Oct 27, 2026), against a price of 47.64 TRY. It is the blended result of 16 valuation models (cash flow, earnings, asset, dividend).
Is AVRUPAKENT GMYO stock overvalued or undervalued in 2026?
As of Oct 27, 2026, AVPGY trades below its calculated fair value: price 47.64 TRY, fair value 118.35 TRY, a gap of about +148% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AVPGY?
No. The price is what the market pays today (47.64 TRY); the fair value is what the company's own numbers justify (118.35 TRY). For AVRUPAKENT GMYO the two are 70.71 TRY per share apart. That gap is exactly why we show both numbers side by side.
How much is AVRUPAKENT GMYO worth?
The market values AVRUPAKENT GMYO at about 19.1B TRY (market capitalisation, as of Oct 27, 2026). Per share that is 47.64 TRY; our models calculate a fair value of 118.35 TRY per share.
What do the bullish and bearish scenarios say about AVPGY?
Our models span a range for AVRUPAKENT GMYO: cautious scenario 73.54 TRY, base 118.35 TRY, optimistic 191.17 TRY per share (as of Oct 27, 2026, price 47.64 TRY). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of AVPGY?
AVRUPAKENT GMYO trades at a price-to-earnings ratio of 10.2 (as of Oct 27, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 118.35 TRY is built from several models across several years. Other multiples: P/B 0.5, P/S 2.9, EV/EBITDA 22.8.
How solid is the balance sheet of AVRUPAKENT GMYO (AVPGY)?
Balance-sheet figures for AVRUPAKENT GMYO (as of Oct 27, 2026): return on equity 2.5%. They feed the Quality Score of 56/100, which measures business quality independently of the share price.
How far is AVPGY from its 52-week high?
AVRUPAKENT GMYO trades at 47.64 TRY, about 25% below its 52-week high of 63.83 TRY and 10% above the low of 43.46 TRY (as of Oct 28, 2026). Distance from the high says nothing about value: that is what the fair value of 118.35 TRY is for.
Which stocks are comparable to AVRUPAKENT GMYO?
From the same area (Real Estate) we also value Henderson Land Development Company, Swiss Prime Site AG, Central Pattana Public Company, The Phoenix Mills Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is AVRUPAKENT GMYO stock attractive at the current price?
The data as of Oct 27, 2026: price 47.64 TRY, calculated fair value 118.35 TRY (+148%), Quality Score 56/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of AVPGY calculated?
We run AVRUPAKENT GMYO through 16 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 118.35 TRY, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.4 % above its aggregate fair value. AVRUPAKENT GMYO currently trades 60 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of AVRUPAKENT GMYO (AVPGY)?
The closing price on Oct 28, 2026 was 47.64 TRY. Our model-based fair value is 118.35 TRY, about +148% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with AVRUPAKENT GMYO right now?
The price is below even our cautious bear case (73.54 TRY). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (56/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (73.54 TRY to 191.17 TRY) leaves room in how you read the outcome.

Key figures of AVRUPAKENT GMYO

How large is the market capitalisation of AVRUPAKENT GMYO (AVPGY)?
The market capitalisation of AVRUPAKENT GMYO is 19.1B TRY (≈ $382M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of AVRUPAKENT GMYO (AVPGY)?
The price-to-sales ratio of AVRUPAKENT GMYO is 2.40 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of AVRUPAKENT GMYO (AVPGY)?
Earnings per share at AVRUPAKENT GMYO are 4.68 TRY (price ÷ EPS = P/E 10.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of AVRUPAKENT GMYO (AVPGY)?
The dividend yield of AVRUPAKENT GMYO is 11.3% (payout 115%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of AVRUPAKENT GMYO (AVPGY)?
The net margin of AVRUPAKENT GMYO is 23.5% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of AVRUPAKENT GMYO (AVPGY)?
The return on equity (ROE) of AVRUPAKENT GMYO is 2.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of AVRUPAKENT GMYO (AVPGY)?
On an EBIT basis the return on assets of AVRUPAKENT GMYO is 7.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of AVRUPAKENT GMYO (AVPGY)?
The operating margin of AVRUPAKENT GMYO is 36.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at AVRUPAKENT GMYO (AVPGY)?
Revenue at AVRUPAKENT GMYO is growing −26.6% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at AVRUPAKENT GMYO (AVPGY)?
Earnings per share at AVRUPAKENT GMYO are growing −31.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does AVRUPAKENT GMYO (AVPGY) carry?
The net debt of AVRUPAKENT GMYO is 5.0M TRY (fiscal year 2023, ≈ 0.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch AVRUPAKENT GMYO in the live analysis

One click puts AVRUPAKENT GMYO on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.